Annual Drug Patent Expirations for NEUPRO Neupro is a drug marketed by Ucb Inc and is included in one NDA. It is available from one supplier. There are eight patents…
The post New patent expiration for Ucb Inc drug NEUPRO appeared first on DrugPatentWa…
Annual Drug Patent Expirations for GIMOTI Gimoti is a drug marketed by Evoke Pharma Inc and is included in one NDA. There are two patents protecting this drug. This drug…
The post New patent expiration for Evoke Pharma drug GIMOTI appeared first on Dru…
New patent expiration for Evoke Pharma drug GIMOTI Read Post »
Annual Drug Patent Expirations for IXEMPRA+KIT Ixempra Kit is a drug marketed by R-pharm Us Llc and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for R-pharm Us drug IXEMPRA KIT appeared first on D…
New patent expiration for R-pharm Us drug IXEMPRA KIT Read Post »
Annual Drug Patent Expirations for IXEMPRA+KIT Ixempra Kit is a drug marketed by R-pharm Us Llc and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for R-pharm Us drug IXEMPRA KIT appeared first on D…
New patent expiration for R-pharm Us drug IXEMPRA KIT Read Post »
XOPENEX (levalbuterol hydrochloride) Akorn Patent: 6,451,289 Expiration: Mar 21, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post D…
Drug Patent Expirations for the Week of March 21, 2021 Read Post »
Annual Drug Patent Expirations for XOPENEX Xopenex is a drug marketed by Akorn and Sunovion and is included in two NDAs. It is available from two suppliers. There are three…
The post New patent expiration for AKORN drug XOPENEX appeared first on DrugPa…
Annual Drug Patent Expirations for NEOPROFEN Neoprofen is a drug marketed by Recordati Rare and is included in one NDA. It is available from two suppliers. There are three patents…
The post New patent expiration for Recordati Rare drug NEOPROFEN appear…
New patent expiration for Recordati Rare drug NEOPROFEN Read Post »
Annual Drug Patent Expirations for ACTOPLUS+MET+XR Actoplus Met Xr is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from one supplier. There…
The post New patent expiration for Takeda Pharms drug ACTOPLUS MET XR appea…
New patent expiration for Takeda Pharms drug ACTOPLUS MET XR Read Post »
Annual Drug Patent Expirations for FORTAMET Fortamet is a drug marketed by Andrx Labs Llc and is included in one NDA. It is available from two suppliers. There are two…
The post New patent expiration for Andrx Labs drug FORTAMET appeared first on DrugP…
New patent expiration for Andrx Labs drug FORTAMET Read Post »
TWIRLA (ethinyl estradiol; levonorgestrel) Agile Patent: 7,045,145 Expiration: Mar 14, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The pos…
Drug Patent Expirations for the Week of March 14, 2021 Read Post »